Pith. sign in

PharmacoNet: Accelerating Large-Scale Virtual Screening by Deep Pharmacophore Modeling

1 Pith paper cite this work. Polarity classification is still indexing.

1 Pith paper citing it
abstract

As the size of accessible compound libraries expands to over 10 billion, the need for more efficient structure-based virtual screening methods is emerging. Different pre-screening methods have been developed for rapid screening, but there is still a lack of structure-based methods applicable to various proteins that perform protein-ligand binding conformation prediction and scoring in an extremely short time. Here, we describe for the first time a deep-learning framework for structure-based pharmacophore modeling to address this challenge. We frame pharmacophore modeling as an instance segmentation problem to determine each protein hotspot and the location of corresponding pharmacophores, and protein-ligand binding pose prediction as a graph-matching problem. PharmacoNet is significantly faster than state-of-the-art structure-based approaches, yet reasonably accurate with a simple scoring function. Furthermore, we show the promising result that PharmacoNet effectively retains hit candidates even under the high pre-screening filtration rates. Overall, our study uncovers the hitherto untapped potential of a pharmacophore modeling approach in deep learning-based drug discovery.

fields

q-bio.BM 1

years

2024 1

verdicts

CONDITIONAL 1

representative citing papers

Pharmacophore-guided de novo drug design with diffusion bridge

q-bio.BM · 2024-12-10 · conditional · novelty 6.0

PharmacoBridge, an SE(3)-equivariant diffusion bridge, generates valid 3D drug-like molecules directly from pharmacophore point clouds and outperforms pocket-based baselines in pharmacophore matching and docking affinity on CrossDocked2020.

citing papers explorer

Showing 1 of 1 citing paper.

  • Pharmacophore-guided de novo drug design with diffusion bridge q-bio.BM · 2024-12-10 · conditional · none · ref 11 · internal anchor

    PharmacoBridge, an SE(3)-equivariant diffusion bridge, generates valid 3D drug-like molecules directly from pharmacophore point clouds and outperforms pocket-based baselines in pharmacophore matching and docking affinity on CrossDocked2020.